Detected ·
Expedition Therapeutics
$115M—
Expedition Therapeutics closed an oversubscribed $115M Series B financing and dosed the first patient in its global Phase 2 clinical trial of EXPD-101 for COPD.
- Website
- www.expeditiontx.com
- Amount
- $115 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-08-05 20:08:42 UTC
- Signal ID
- 85a2b33d-5165-43c7-866c-b0ae828b0d12
As the API returns it
{
"id": "85a2b33d-5165-43c7-866c-b0ae828b0d12",
"created_at": "2026-08-05T20:08:42.961847Z",
"company_name": "Expedition Therapeutics",
"company_website_url": "www.expeditiontx.com",
"company_linkedin_url": "https://www.linkedin.com/company/expedition-therapeutics-inc",
"event_type": "funding",
"funding_amount": 115000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Expedition Therapeutics closed an oversubscribed $115M Series B financing and dosed the first patient in its global Phase 2 clinical trial of EXPD-101 for COPD.*"
}